Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Citation: Boominathan, MiRNA-based therapy for Pulmonary arterial Hypertension: Endothelin-1 exacerbates pulmonary arterial hypertension through up regulation of its target gene, 23/October/2014, 22.26, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Significance: This study suggests that Endothelin-1, by increasing the expression of its target gene, it may aggravate pulmonary arterial hypertension. Thus, pharmacological formulations encompassing ” Endothelin-1 inhibitors“ may be used to treat pulmonary arterial hypertension.
Amount: $300
Undisclosed information: An insight into how Endothelin-1 suppresses pulmonary arterial hypertension.
Courtesy: When you cite drop us a line at info@genomediscovery.org
Web: http://genomediscovery.org